, , , ,
doi.org/10.1007/PL00004171, hdl.handle.net/1765/74125
Osteoporosis International: with other metabolic bone diseases
Department of Internal Medicine

Pols, H., Felsenberg, D., Hanley, G., Štepán, J., Muñoz-Torres, M., Wilkin, T., … Stych, B. (1999). Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study. Osteoporosis International: with other metabolic bone diseases, 9(5), 461–468. doi:10.1007/PL00004171